Repare Therapeutics

This early-stage trial tested an experimental pill called RP-1664 in people with advanced solid tumors that had stopped responding to other treatments. The goal was to find a safe dose and see if the drug could shrink tumors. The study was stopped early, so results are limited.

This early-stage trial tested a new drug called RP-3467, alone or with another drug (olaparib), in 26 adults with advanced solid tumors that had stopped responding to standard treatments. The main goal was to check safety and find the right dose. The study was terminated early, s…